United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies

Curr Probl Cancer. 2013 May-Jun;37(3):110-44. doi: 10.1016/j.currproblcancer.2013.06.001.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Humans
  • Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / administration & dosage*
  • Protein Kinase Inhibitors / adverse effects
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors